IDEAYA Biosciences, Inc. IDYA
Set alert
31.64 USD -0.32 -1.00%
At close · Nov 2
31.64 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
31.10 Day range 32.42
26.81 52-week range 42.68
- YTD
- -8.48%
- 1 year
- -0.69%
- Open
- 32.14
- Prev close
- 31.96
- Mkt cap
- 3.05B
- Vol
- 789.94K
- Avg vol
- 818.03K
- EPS
- -1.92
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 31.10
- High
- 32.42
- Forward P/E
- -7.69
- Beta
- 0.08
- Short ratio
- 9.87
- Inst. own
- 107.62%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 37.24
- 200-d avg
- 34.02
- 1y target
- 51.92
MAX chart
Events in this range
- Aug 5, 2025Earnings: -0.88; estimate -0.85; surprise -3.53%
- Nov 4, 2025Earnings: 1.33; estimate -0.94597; surprise 240.6%
- Feb 17, 2026Earnings: -0.94; estimate -0.95172; surprise 1.23%
- May 5, 2026Earnings: -1.11; estimate -1.07; surprise -3.74%
- Aug 4, 2026Earnings: -1.22; estimate -1.06; surprise -15.09%
- Aug 5, 2026Rating: Wedbush · Outperform → Outperform
- Aug 5, 2026Rating: Truist Securities · Buy → Buy
- Sep 1, 2026Rating: Citizens · Market Outperform → Market Outperform
- Sep 9, 2026Rating: Guggenheim · Buy → Buy
- Oct 14, 2026Rating: Stifel · — → Buy
- Oct 16, 2026Rating: William Blair · — → Outperform
Signals (120)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 19, 2026 | 9 months ago |
| RSI: Overbought | Nov 24, 2025 | 11 months ago |
Newest 20 of 120.
Financial health
Altman Z-Score
15.95 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -27.0×
FY 2017 5y median -16.8× FY 2025
P/S 14.0×
FY 2017 5y median 29.8× FY 2025
P/B 3.0×
FY 2017 5y median 2.8× FY 2025
P/FCF -41.6×
FY 2017 5y median -14.3× FY 2025
EV/EBITDA -19.2×
FY 2017 5y median -15.5× FY 2025
EV/Sales 13.6×
FY 2017 5y median 26.7× FY 2025
FCF Yield -2.4%
FY 2017 5y median -7.0% FY 2025
Profitability
Gross Margin -43.9%
FY 2017 5y median 82.9% FY 2025
Operating Margin -72.8%
FY 2017 5y median -179.9% FY 2025
Net Margin -52.0%
FY 2017 5y median -178.1% FY 2025
ROE -11.1%
FY 2017 5y median -16.8% FY 2025
ROIC -15.2%
FY 2017 5y median -17.5% FY 2025
ROA -10.2%
FY 2017 5y median -15.1% FY 2025
Growth (YoY)
Revenue 3024.4%
FY 2017 FY 2025
Operating Income 51.3%
FY 2017 FY 2025
EPS (diluted) 61.9%
FY 2017 FY 2025
Free Cash Flow 70.8%
FY 2017 FY 2025
Financial Health
Current Ratio 11.3×
FY 2017 5y median 11.7× FY 2025
Quick Ratio 11.3×
FY 2017 5y median 11.7× FY 2025
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2017 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
